Madrigal Pharmaceuticals (MDGL) Price to Sales (2010 - 2026)
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Price to Sales (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Madrigal Pharmaceuticals | 15.80 Bn | 14.96 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.96 |
| Mar 31, 2026 | 48.81 |
| Dec 31, 2025 | 41.43 |
| Sep 30, 2025 | 36.25 |
| Jun 30, 2025 | 31.60 |
| Mar 31, 2025 | 53.55 |
| Dec 31, 2024 | 65.72 |
| Sep 30, 2024 | 74.43 |
| Jun 30, 2024 | 380.40 |
| Sep 30, 2012 | 112,270.00 |
| Jun 30, 2012 | 75,294.49 |
| Mar 31, 2012 | 60,246.59 |
| Dec 31, 2011 | 2,365.55 |
| Sep 30, 2011 | 3,383.68 |
| Jun 30, 2011 | 6,432.60 |
| Mar 31, 2011 | 6,766.25 |
| Dec 31, 2010 | 2,233.27 |
| Sep 30, 2010 | 1,667.00 |
| Jun 30, 2010 | 1,134.64 |